Have a question?
Please get in touch with our team in case of any queries
GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE TO CROSS USD 24 BILLION BY 2025, GROWING AT A CAGR OF 7% DURING THE FORECAST PERIOD
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (REVENUE) | USD 24 Billion (2025) |
| CAGR | 7% (2020-2025) |
| Base Year | 2019 |
| Forecast Year | 2020-2025 |
| Market Segments | Product (Instruments/Analyzers and Software and Consumables), Disease (Hepatitis, AIDS, HAIs, Influenza, Tuberculosis, Malaria, HPV Infection, Sepsis, Dengue, and Other Diseases), End-users (Hospitals, Standard Reference Laboratories, Public Health Laboratories, Blood Banks, Acute Care Settings, and Others), Test (Traditional Diagnostics and Molecular Diagnostics) |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, and Turkey |
INDUSTRY INSIGHTS
The global infectious disease diagnostics market size to cross USD 24 billion by 2025, growing at a CAGR of over 7% during the forecast period. The global infectious disease diagnostics market, which is one of the major segments in the global in-vitro diagnostics market, is likely to grow at a steady rate during the forecast period. The growth can be attributed to the growing prevalence/incidence of several infectious diseases. Malaria continues to be a major cause of death in the Middle East and Africa. The market is witnessing growth due to the increase in the usage of diagnostics testing for several purposes, including routine health checkups, infectious diseases, seasonal flu. Improvements in technology such as the introduction of automated analyzers, advanced devices with high throughput with reduced waiting time and point-of-care testing & diagnostics, and the ability to perform a large volume of tests in a shorter duration of time are fueling the global infectious disease diagnostics market growth.
SNIPPETS
- The molecular segment is expected to grow at the highest CAGR of over 10% during the period 2019–2025 due to the increased revenue contribution of polymerase chain reaction (PCR) technology.
- The hospital-acquired infections (HAIs) segment is likely to reach over $9 billion by 2025. The usage of diagnostic techniques to diagnose several HAIs is considered as an important step to initiate several preventive measures.
- The consumable segment is likely to observe an incremental growth of over $7 billion by 2025 on account of the increasing sale of high-end instruments by hospitals, commercial labs, and other facilities.
- The standard reference laboratories segment is projected to over $8 billion by 2025, owing to the rise of private laboratories, especially in developing countries.
- The infectious disease diagnostics market in India is likely to grow at a CAGR of over 8% during the period 2019–2025 on account of the rapidly growing patient pool with infectious diseases and increased market access.
GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION
This research report includes a detailed segmentation by
- Products
- Disease
- End-user
- Tests
- Geography
INSIGHTS BY TEST
In 2019, the traditional diagnostics segment accounted for 66% of the infectious disease diagnostics market share. The segment is growing at a moderate rate than molecular diagnostics. Conventional diagnostics include immunodiagnostics, blood culture tests, and clinical, microbiological methods to diagnose several diseases. However, the infectious disease molecular diagnostics market is rapidly capturing the revenue share of the traditional segment. Molecular diagnostic tests are based on DNA amplification techniques. They have comparatively higher sensitivity and specificity than immunoassays. Most tests are based on real-time PCR. However, these tests are comparatively complicated and expensive.
INSIGHTS BY DISEASE
Tuberculosis (TB) segment is expected to be one of the major revenue contributors by 2025. By the end of 2018, around 10 million people were infected with TB, including 5.7 million men, 3.2 million women, and 1.1 million children. Therefore, the increasing burden of TB disease across the world, especially in India, China, South Africa, and Bangladesh constituting a significant percentage of TB cases, is likely to influence the segment growth.
The hepatitis segment is likely to grow at a CAGR of over 4% during the period 2019–2025. The staggering rise in liver damage cases due to viral infections, drug, and chemical abuses, and an increase in alcohol intake, is contributing to the growth of the segment. The presence of a high pool of infected patients who are undiagnosed and need urgent diagnosis is another driver influencing the segment growth.
Improvements and enhancements in infectious disease testing methods for HIV testing and sexually transmitted disease is a major driver for the segment growth. Conventional methods for HIV testing, based on the detection of HIV-specific antibodies, have been improved over time, gaining in sensitivity and specificity. Kits that allow simultaneous determination of both HIV-specific antibodies and the p24 antigen have been recently introduced, thereby increasing the demand. There is a widespread concern of adverse effects of hospital-acquired infections (HAIs), which are increasing the market share of the Healthcare-associated Infections Diagnostics Market. Healthcare providers and vendors are actively engaged in providing an expedited diagnosis of HAIs for quick clinical decision-making to support treatment regimens.
INSIGHTS BY END-USER
The hospital end-user segment dominated the infectious disease diagnostics market shares. It accounted for the highest market share of over 34% in 2019 due to the high volume of infectious disease diagnosis and treatment performed in these settings. The large number of private hospitals, which have their central laboratories performing a high volume of tests, is a major factor influencing the market growth. Standard reference laboratories accounted for a share of 33% share. The number of standard reference laboratories (both private and public run labs) is increasing in large cities and urban areas of developing countries and developed countries due to an increase in epidemic conditions and the rise in prevalence of several infectious diseases such as malaria, dengue, and HIV. The demand for diagnosis is higher and plays a vital role in preventing the spread of acute diseases and take immediate preventive measures as well as help in making critical clinical decisions regarding treatment regimens. Public health laboratories accounted for a share of 12% in the end-user segment.
INSIGHTS BY PRODUCT
In 2019, the consumables segment accounted for 74% of the global infectious disease diagnostics market shares. The increasing share of consumables is due to the usage of a wide array of several standard reagents and test kits to perform various tests catering to the need of end-users. The usage of consumables is reoccurring in nature, and the consumables segment generates continuous revenue for vendors.
The instruments/ analyzers segment includes the capital equipment such as analyzers, rapid diagnostics kit, assay instruments used for performing the routine as well as specialized tests. However, with rapid technological advancements, vendors are offering highly automated and semi-automated analyzers, which are replacing conventional testing methods. As the lifespan of analyzers is higher, they do not require repetitive purchases. The sale of the latest instruments /analyzers is higher in developed countries than in developing and under-developing countries due to the economic factors impacting the purchase of the advanced, costly equipment for the analysis.
INSIGHTS BY GEOGRAPHY
APAC is expected to grow at the highest CAGR of over 8% during the period 2019–2025. The region is witnessing the highest growth rate due to the high prevalence of infectious diseases in countries such as China, India, Japan, Australia, and South Korea. It is home to more than half of the world’s population, and the bulk of this population is still hugely underserved. The region is made up of diverse countries with varying needs. There are certain countries whose healthcare segment is developed, and a few countries’ healthcare infrastructures are still in infancy. However, the diagnostics market will have a high growth rate in this region due to the increase in infectious disease, combined with the aging population, which has put immense pressure on the healthcare resources in the region.
INSIGHTS BY VENDORS
The global infectious disease diagnostics industry is highly dynamic, with the presence of several global and local players offering a diverse range of instruments/analyzers and reagents. Abbott, BD, bioMérieux, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Luminex, Quidel, and Thermo Fisher Scientific are the leading players and accounted for significant shares in the market. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio.
The global infectious disease testing market report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
By Products
- Instruments/ Analyzers and Software
- Consumables
By Disease
- Hepatitis
- AIDS
- HAIs
- Influenza
- Tuberculosis
- Malaria
- HPV Infection
- Sepsis
- Dengue
- Other Diseases
By End-user
- Hospitals
- Standard Reference Laboratories
- Public Health Laboratories
- Blood Banks
- Acute Care Settings
- Others
By Test
- Traditional Diagnostics
- Molecular Diagnostics
By Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- APAC
- China
- Japan
- South Korea
- Australia
- India
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- Turkey
- Iran
Frequently Asked Questions
What is the infectious disease diagnostics market size and growth rate during the forecast period?
What are the factors impacting the growth of the global infectious disease diagnostics market shares?
Which product type/end-users/region is generating the largest revenue in the global market?
Who are the leading vendors in the infectious disease diagnostics market, and what are their market shares?
How is the growth of the hospital segment influencing the growth of the infectious disease diagnostics market?
The infectious disease diagnostics market by revenue is expected to grow at a CAGR of over 7% during the period 2019–2025.
The following factors are likely to contribute to the growth of the infectious disease diagnostics market during the forecast period:
- High Growth Potential in LMICs
- Increasing Demand for Molecular Diagnostics
- Strategic Merges and Acquisitions
- Increased Prevalence of infectious Diseased Globally
Base Year: 2019
Forecast Year: 2020–2025
The study considers the present scenario of the infectious disease diagnostics market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Prominent Vendors
- Abbott
- Business Overview
- Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
- BD
- bioMérieux
- Hoffmann-La Roche
- Thermo Fisher Scientific
- Quidel
- Luminex
- Danaher
- Bio-Rad Laboratories
Other Prominent Vendors
- Meridian Bioscience
- Business Overview
- Product Offerings
- DiaSorin Molecular
- Accelerate Diagnostics
- Trinity Biotech
- OpGen
- QIAGEN
- Siemens Healthineers
- caviid
- EIKEN CHEMICAL
- Epitope Diagnostics Inc.
- EUROIMMUN
- Genetic Signatures
- Hologic
- Oxford Immunotec
- Seegene
Segmentation by Products
- Instruments/ Analyzers & Software
- Consumables
Segmentation by Disease
- Hepatitis
- AIDS
- HAIs
- Influenza
- Tuberculosis
- Malaria
- HPV Infection
- Sepsis
- Dengue
- Other Diseases
Segmentation by End-user
- Hospitals
- Standard Reference Laboratories
- Public Health Laboratories
- Blood Banks
- Acute Care Settings
- Others
Segmentation by Test
- Traditional Diagnostics
- Molecular Diagnostics
Segmentation by Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- APAC
- China
- Japan
- South Korea
- Australia
- India
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- Turkey
- Iran
List Of Exhibits
Exhibit 1 Segmentation of Global Infectious Disease Diagnostics Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Impact of High Growth Potential in LMICs
Exhibit 4 Leading Causes of Death in Low-Income Countries -2016 (deaths per 100,000 Population)
Exhibit 5 Impact of Increasing Demand for Molecular Diagnostics
Exhibit 6 Number of Death Globally due to Drug-Resistant Infections
Exhibit 7 Impact of Strategic Merges and Acquisitions
Exhibit 8 Impact of Increase in the Worldwide Prevalence of Infectious Diseases
Exhibit 9 Regional Prevalence of Several Infectious Diseases
Exhibit 10 Global Number of Human Infectious Disease Outbreaks and Pathogen Taxonomy (Past four decades comparison)
Exhibit 11 Impact of Shift from Centralized Laboratories to Point of Care Testing
Exhibit 12 Impact of Technological Advancements and Launch of More Reliable Products
Exhibit 13 Impact of Availability of Advanced Control Mechanism for Infectious Disease
Exhibit 14 The Control Mechanism for the Infectious Diseases
Exhibit 15 Steps & Strategies by the WHO for Infectious Diseases
Exhibit 16 Impact of Inadequate Reimbursement
Exhibit 17 Effects of Limitations to Reimbursement System
Exhibit 18 Impact of Poor Healthcare Infrastructure and Less Affordability in LMICs
Exhibit 19 Availability of Healthcare Service
Exhibit 20 Global Infectious Disease Diagnostics Market by Product
Exhibit 21 Global Infectious Disease Diagnostics Market by Test
Exhibit 22 Global Infectious Disease Diagnostics Market by Disease
Exhibit 23 Global Infectious Disease Diagnostics Market by End-user
Exhibit 24 Global Infectious Disease Diagnostics Market by Geography
Exhibit 25 Global Infectious Disease Diagnostics Market 2019–2025 ($ billion)
Exhibit 26 Five Forces Analysis 2019
Exhibit 27 Incremental Growth by Test 2019 & 2025
Exhibit 28 Global Infectious Disease Diagnostics Market by Test
Exhibit 29 Global Market by Test: Incremental Growth ($ billion)
Exhibit 30 Global Market by Test: Absolute Growth (%)
Exhibit 31 Global Market by Traditional Diagnostics: Incremental Growth Versus Absolute Growth
Exhibit 32 Global Market – Traditional Diagnostics 2019–2025 ($ billion)
Exhibit 33 Global Market by Molecular Diagnostics: Incremental Growth Versus Absolute Growth
Exhibit 34 Global Market- Molecular Diagnostics 2019–2025 ($ billion)
Exhibit 35 Incremental Growth by Disease 2019 & 2025
Exhibit 36 Global Infectious Disease Diagnostics Market by Disease
Exhibit 37 Global Market by Hepatitis Disease: Incremental Growth Versus Absolute Growth
Exhibit 38 Global Market – Hepatitis 2019–2025 ($ billion)
Exhibit 39 Prevalence of HIV by Region
Exhibit 40 Global Market by HIV Disease: Incremental Growth Versus Absolute Growth
Exhibit 41 Global Market – HIV 2019–2025 ($ billion)
Exhibit 42 Global Hospital Acquired Market by Infection Type 2018 (%)
Exhibit 43 Global Market by HAI: Incremental Growth Versus Absolute Growth
Exhibit 44 Global Market- HAI 2019–2025 ($ billion)
Exhibit 45 Global Market by Influenza: Incremental Growth Versus Absolute Growth
Exhibit 46 Global Market – Influenza 2019–2025 ($ billion)
Exhibit 47 Regional Prevalence of TB
Exhibit 48 Global Market by TB: Incremental Growth Versus Absolute Growth
Exhibit 49 Global Market– Tuberculosis2019–2025 ($ billion)
Exhibit 50 Global Market by Malaria: Incremental Growth Versus Absolute Growth
Exhibit 51 Global Market- Malaria 2019–2025 ($ billion)
Exhibit 52 Global Market by HPV: Incremental Growth Versus Absolute Growth
Exhibit 53 Global Market – HPV 2019–2025 ($ billion)
Exhibit 54 Global Market by Sepsis: Incremental Growth Versus Absolute Growth
Exhibit 55 Global Market – Sepsis 2019–2025 ($ billion)
Exhibit 56 Global Market by Dengue: Incremental Growth Versus Absolute Growth
Exhibit 57 Global Market – Dengue 2019–2025 ($ billion)
Exhibit 58 Global Market by Other Diseases: Incremental Growth Versus Absolute Growth
Exhibit 59 Global Market- Other Diseases 2019–2025 ($ billion)
Exhibit 60 Incremental Growth by Product 2019 & 2025
Exhibit 61 Global Infectious Disease Diagnostics Market by Product
Exhibit 62 Global Market by Product: Incremental Growth ($ billion)
Exhibit 63 Global Market by Product: Absolute Growth (%)
Exhibit 64 Global Market by Consumables: Incremental Growth Versus Absolute Growth
Exhibit 65 Global Market- Consumables 2019–2025 ($ billion)
Exhibit 66 Global Market by Instruments/Analyzers & Software: Incremental Growth Versus Absolute Growth
Exhibit 67 Global Market – Instrument /Analyzers & Software 2019–2025 ($ billion)
Exhibit 68 Incremental Growth by End-User 2019 & 2025
Exhibit 69 Global Infectious Disease Diagnostics Market by End-User
Exhibit 70 Global Market by End-user: Incremental Growth ($ billion)
Exhibit 71 Global Market by Hospitals: Incremental Growth Versus Absolute Growth
Exhibit 72 Global Infectious Diagnostics Market- Hospitals 2019–2025 ($ billion)
Exhibit 73 Global Market by Standard Reference Laboratories: Incremental Growth Versus Absolute Growth
Exhibit 74 Global Market- Standard Reference Laboratories 2019–2025 ($ billion)
Exhibit 75 Global Market by Public Health Laboratories: Incremental Growth Versus Absolute Growth
Exhibit 76 Global Market – Public Health Laboratories 2019–2025 ($ billion)
Exhibit 77 Global Market by Blood Banks: Incremental Growth Versus Absolute Growth
Exhibit 78 Percentage Share of Blood Donations in Various Countries by Income
Exhibit 79 Global Market- Blood Banks 2019–2025 ($ billion)
Exhibit 80 Global Market by Acute Care Settings: Incremental Growth Versus Absolute Growth
Exhibit 81 Global Market-Acute Care Settings 2019–2025 ($ billion)
Exhibit 82 Global Market by Other End-User: Incremental Growth Versus Absolute Growth
Exhibit 83 Global Market- Other End-User 2019–2025 ($ billion)
Exhibit 84 Incremental Growth by Geography 2019 & 2025
Exhibit 85 Global Infectious Disease Diagnostics Market by Geography
Exhibit 86 Global Market by Geography: Incremental Growth ($ billion)
Exhibit 87 Global Market by Geography: Absolute Growth (%)
Exhibit 88 Infectious Disease Diagnosis Market in APAC: Key Countries 2019 ($ billion)
Exhibit 89 Infectious Disease Diagnostics Market in APAC: Incremental Growth Versus Absolute Growth Comparison
Exhibit 90 Market in APAC 2019–2025 ($ billion)
Exhibit 91 Incremental Growth in APAC 2019 & 2025
Exhibit 92 Market in China 2019–2025 ($ billion)
Exhibit 93 Market in Japan 2019–2025 ($ billion)
Exhibit 94 Market in India 2019–2025 ($ billion)
Exhibit 95 Market in South Korea 2019–2025 ($ billion)
Exhibit 96 Market in Australia 2019–2025 ($ billion)
Exhibit 97 Infectious Disease Diagnosis Market in Europe: Key Countries 2019 ($ million)
Exhibit 98 Infectious Disease Diagnostics Market in Europe: Incremental Growth Versus Absolute Growth Comparison
Exhibit 99 European IVD Market Per capita – 2018 (Euros - million)
Exhibit 100 European IVD Market – 2018 (Euros - million)
Exhibit 101 Market in Europe 2019–2025 ($ billion)
Exhibit 102 Incremental Growth in Europe 2019 & 2025
Exhibit 103 Market in Germany 2019–2025 ($ billion)
Exhibit 104 Market in France 2019–2025 ($ billion)
Exhibit 105 Market in UK 2019–2025 ($ billion)
Exhibit 106 Market in Italy 2019–2025 ($ billion)
Exhibit 107 Market in Spain 2019–2025 ($ billion)
Exhibit 108 Infectious Disease Diagnosis Market in North America: Key Countries 2019 ($ billion)
Exhibit 109 Infectious Disease Diagnostics Market in North America: Incremental Growth Versus Absolute Growth Comparison
Exhibit 110 Market in North America 2019–2025 ($ billion)
Exhibit 111 Incremental Growth in North America 2019 & 2025
Exhibit 112 Market in US 2019–2025 ($ billion)
Exhibit 113 New Cases of Infectious Disease 2016 & 2017
Exhibit 114 Number of Labs by Type in US
Exhibit 115 Percentage of Lab Test Volumes
Exhibit 116 Market in Canada 2019–2025 ($ billion)
Exhibit 117 Infectious Disease Diagnosis Market in Latin America: Key Countries 2019 ($ billion)
Exhibit 118 Infectious Disease Diagnostics Market in Latin America: Incremental Growth Versus Absolute Growth Comparison
Exhibit 119 Market in Latin America 2019–2025 ($ billion)
Exhibit 120 Incremental Growth in Latin America 2019 & 2025
Exhibit 121 Market in Brazil 2019–2025 ($ billion)
Exhibit 122 Market in Mexico 2019–2025 ($ billion)
Exhibit 123 Market in Argentina 2019–2025 ($ billion)
Exhibit 124 Infectious Disease Diagnosis Market in Middle East and Africa: Key Countries 2019 ($ billion)
Exhibit 125 Infectious Disease Diagnostics Market in Middle East and Africa: Incremental Growth Versus Absolute Growth Comparison
Exhibit 126 Market in Middle East and Africa 2019–2025 ($ billion)
Exhibit 127 Incremental Growth in Middle East & Africa 2019 & 2025
Exhibit 128 Market in South Africa 2019–2025 ($ billion)
Exhibit 129 Market in Turkey 2019–2025 ($ billion)
Exhibit 130 Market in Saudi Arabia 2019–2025 ($ billion)
Exhibit 131 Market in Iran 2019–2025 ($ billion)
Exhibit 132 Global Infectious Disease Diagnostics Market: Vendors Market Share
Exhibit 133 Abbott: Sales Breakdown by Segments in 2018 & 2019 ($ million)
Exhibit 134 Abbott: Net Sales 2017−2019 ($ million)
Exhibit 135 Abbott: Net Sales breakdown by Diagnostics Product Segment 2018 & 2019 ($ million)
Exhibit 136 BD Revenue 2017−2019 ($ million)
Exhibit 137 BD: Research & Development Expenditure 2017−2019 ($million)
Exhibit 138 BD Revenue by Business Segment (billion)
Exhibit 139 F. Hoffmann-La Roche: Revenue by Segment 2018 & 2019 ($ billion)
Exhibit 140 F. Hoffmann-La Roche: Revenue by Geographies 2019 (%)
Exhibit 141 Thermo Fisher Scientific: Revenue 2017−2019 ($ million)
Exhibit 142 Thermo Fisher Scientific: Revenue by Geography 2019 (%)
Exhibit 143 Danaher: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 144 Danaher: Net Sales 2017−2019 ($ million)
Exhibit 145 Danaher: Revenue by Geography 2019
Exhibit 146 Danaher: R&D Expenditure 2017−2019 ($ million)
Exhibit 147 Danaher: Diagnostics Segment Sales 2017−2019 ($ million)
Exhibit 148 Bio-Rad Laboratories: Net Sales by Geography 2019 ($ million)
Exhibit 149 Bio-Rad Laboratories Net Sales 2017−2019 ($ million)
Exhibit 150 Bio-Rad Laboratories: Net Sales by Segment 2018 & 2019 ($ million)
Exhibit 151 Bio-Rad Laboratories: R&D Expenditure 2017−2019 ($ million)
List Of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2019
Table 3 Prominent Outbreaks, Epidemics and Pandemics
Table 4 Main Causes of Death due to Infectious Diseases
Table 5 Comparison of Absolute Growth in High Income and LMICs
Table 6 Popular Mergers and Acquisitions in Infectious Disease Diagnostics Market
Table 7 Recent Product Approval/Launch for Infectious Disease Diagnostics
Table 8 Incremental & Absolute Growth Comparison – Disease (billion)
Table 9 Various Diagnostics for HIV
Table 10 Influenza Virus Diagnosis Methods
Table 11 Diagnostic Tests for Malaria
Table 12 FDA Approved Laboratory Test for Human Papillomavirus
Table 13 Product Offerings For Other Infectious Diseases
Table 14 Commonly Performed Tests for the Donor Blood Samples
Table 15 Abbott: Major Product Offerings
Table 16 BD: Major Product Offerings
Table 17 bioMerieux: Major Product Offerings
Table 18 F.Hoffmann-LaRoche: Major Product Offerings
Table 19 Thermo Fisher Scientific: Major Product Offerings
Table 20 Quidel: Major Product Offerings
Table 21 Luminex: Major Product Offerings
Table 22 Danaher: Major Product Offerings
Table 23 Bio-Rad Laboratories: Major Product Offerings
Table 24 Meridian Bioscience: Major Product Offerings
Table 25 DiaSorin Molecular: Major Product Offerings
Table 26 Accelerate Diagnostics: Major Product Offerings
Table 27 Trinity Biotech: Major Product Offerings
Table 28 OpGen: Major Product Offerings
Table 29 Qiagen: Major Product Offerings
Table 30 Siemens Healthineers: Major Product Offerings
Table 31 cavidi: Major Product Offerings
Table 32 EIKEN CHEMICAL: Major Product Offerings
Table 33 Epitope Diagnostics: Major Product Offerings
Table 34 EUROIMMUN: Major Product Offerings
Table 35 Genetic Signatures: Major Product Offerings
Table 36 Hologic: Major Product Offerings
Table 37 Oxford Immunotec: Major Product Offerings
Table 38 Seegene: Major Product Offerings
Table 39 Global Infectious Disease Diagnostics Market by Geography 2019−2025 ($ billion)
Table 40 Global Market by Geography 2019−2025 (%)
Table 41 Global Infectious Disease Diagnostics Market by End-user 2019−2025 ($ billion)
Table 42 Global Market by End-User 2019−2025 (%)
Table 43 Global Infectious Disease Diagnostics Market by Test 2019−2025 ($ billion)
Table 44 Global Market by Test 2019−2025 (%)
Table 45 Global Infectious Disease Diagnostics Market by Product 2019−2025 ($ billion)
Table 46 Global Market by Product 2019−2025(%)
Table 47 Global Infectious Disease Diagnostics Market by Disease 2019−2025 ($ billion)
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusion
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Test
4.4.3 Market Segmentation by Disease
4.4.4 Market Segmentation by End-User
4.4.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Market Opportunities & Trends
8.1 High Growth Potential In Low And Middle Income Countries (LMICS)
8.2 Increasing Demand For Molecular Diagnostics
8.3 Strategic Merges and Acquisitions
9 Market Growth Enablers
9.1 Increase In The Worldwide Prevalence Of Infectious Diseases
9.2 Shift From Centralized Laboratories To Point Of Care Testing
9.3 Technological Advancements And Launch Of More Reliable Products
10 Market Restraints
10.1 Availability of Advanced Control Mechanism For Infectious Disease
10.2 Inadequate Reimbursement
10.3 Poor Healthcare Infrastructure And Less Affordability In LMICS
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Infectious Disease Diagnostics Market by Test
12.1 Market Snapshot & Growth Engine
12.2 Overview
12.3 Traditional Diagnostics
12.3.1 Overview
12.3.2 Size & Forecast
12.4 Molecular Diagnostics
12.4.1 Overview
12.4.2 Size & Forecast
13 Infectious Disease Diagnostics Market by Disease
13.1 Market Snapshot & Growth Engine
13.2 Overview
13.3 Hepatitis
13.3.1 Overview
13.3.2 Size & Forecast
13.4 HIV
13.4.1 Overview
13.4.2 Size & Forecast
13.5 Hospital Acquired Infections (HAIs)
13.5.1 Overview
13.5.2 Size & Forecast
13.6 Influenza
13.6.1 Overview
13.6.2 Size & Forecast
13.7 Tuberculosis
13.7.1 Overview
13.7.2 Size & Forecast
13.8 Malaria
13.8.1 Overview
13.8.2 Size & Forecast
13.9 Human Papilloma Virus
13.9.1 Overview
13.9.2 Size & Forecast
13.10 SEPSIS
13.10.1 Overview
13.10.2 Size & Forecast
13.11 Dengue
13.11.1 Overview
13.11.2 Size & Forecast
13.12 Other Infectious Diseases
13.12.1 Overview
13.12.2 Size & Forecast
14 Infectious Disease Diagnostics Market by Product
14.1 Market Snapshot & Growth Engine
14.2 Overview
14.3 Consumables
14.3.1 Overview
14.3.2 Size & Forecast
14.4 Instruments/Analyzers & Software
14.4.1 Overview
14.4.2 Size & Forecast
15 Infectious Disease Diagnostics Market by End-User
15.1 Market Snapshot & Growth Engine
15.2 Overview
15.3 Hospitals
15.3.1 Overview
15.3.2 Size & Forecast
15.4 Standard Reference Laboratories
15.4.1 Overview
15.4.2 Size & Forecast
15.5 Public Health Laboratories
15.5.1 Overview
15.5.2 Size & Forecast
15.6 Blood Banks
15.6.1 Overview
15.6.2 Size & Forecast
15.7 Acute Care Settings
15.7.1 Overview
15.7.2 Size & Forecast
15.8 Other End-User
15.8.1 Overview
15.8.2 Size & Forecast
16 Infectious Disease Diagnostics Market by Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 APAC
17.1 Market Overview
17.2 Size & Forecast
17.3 Key Countries
17.3.1 China: Infectious Disease Diagnostics Market Size & Forecast
17.3.2 Japan: Size & Forecast
17.3.3 India: Size & Forecast
17.3.4 South Korea: Size & Forecast
17.3.5 Australia: Size & Forecast
18 Europe
18.1 Market Overview
18.2 Size & Forecast
18.3 Key Countries
18.3.1 Germany: Infectious Disease Diagnostics Market Size & Forecast
18.3.2 France: Size & Forecast
18.3.3 UK: Size & Forecast
18.3.4 Italy: Size & Forecast
18.3.5 Spain: Size & Forecast
19 North America
19.1 Market Overview
19.2 Size & Forecast
19.3 Key Countries
19.3.1 US: Infectious Disease Diagnostics Market Size & Forecast
19.3.2 Canada: Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Size & Forecast
20.3 Key Countries
20.3.1 Brazil: Infectious Disease Diagnostics Market Size & Forecast
20.3.2 Mexico: Size & Forecast
20.3.3 Argentina: t Size & Forecast
21 Middle East and Africa
21.1 Market Overview
21.2 Size & Forecast
21.3 Key Countries
21.3.1 South Africa: Infectious Disease Diagnostics Market Size & Forecast
21.3.2 Turkey: Size & Forecast
21.3.3 Saudi Arabia: Size & Forecast
21.3.4 Iran: Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Abbott
22.2.2 BD
22.2.3 bioMérieux
22.2.4 DANAHER
22.2.5 Bio-Rad Laboratories
22.2.6 F.Hoffmann-LaRoche
22.2.7 Luminex
22.2.8 Quidel
22.2.9 Thermo Fischer Scientific
23 Key Company Profiles
23.1 Abbott in Infectious Disease Diagnostics Market
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 BD in Infectious Disease Diagnostics Market
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 bioMérieux in Infectious Disease Diagnostics Market
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 F.Hoffmann-La Roche in Infectious Disease Diagnostics Market
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Thermo Fisher Scientific in Infectious Disease Diagnostics Market
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
23.6 Quidel in Infectious Disease Diagnostics Market
23.6.1 Business Overview
23.6.2 Product Offerings
23.6.3 Key Strategies
23.6.4 Key Strengths
23.6.5 Key Opportunities
23.7 Luminex in Infectious Disease Diagnostics Market
23.7.1 Business Overview
23.7.2 Product Offerings
23.7.3 Key Strategies
23.7.4 Key Strengths
23.7.5 Key Opportunities
23.8 Danaher in Infectious Disease Diagnostics Market
23.8.1 Business Overview
23.8.2 Product Offerings
23.8.3 Key Strategies
23.8.4 Key Strengths
23.8.5 Key Opportunities
23.9 Bio-Rad Laboratories in Infectious Disease Diagnostics Market
23.9.1 Business Overview
23.9.2 Product Offerings
23.9.3 Key Strategies
23.9.4 Key Strengths
23.9.5 Key Opportunities
24 Other Prominent Vendors
24.1 Meridian Bioscience
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 DiaSorin Molecular
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 Accelerate Diagnostics
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Trinity Biotech
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 OpGen
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Qiagen
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Siemens Healthineers
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 cavidi
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 EIKEN Chemical
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Epitope Diagnostics
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Euroimmun
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 Genetic Signatures
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 Hologic
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 Oxford Immunotec
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Seegene
24.15.1 Business Overview
24.15.2 Product Offerings
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
26.1 Market By Geography
26.2 Market By End-User
26.3 Market By Test
26.4 Market By Product
26.5 Market By Disease
27 Appendix
27.1 Abbreviations
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
What is the infectious disease diagnostics market size and growth rate during the forecast period?
What are the factors impacting the growth of the global infectious disease diagnostics market shares?
Which product type/end-users/region is generating the largest revenue in the global market?
Who are the leading vendors in the infectious disease diagnostics market, and what are their market shares?
How is the growth of the hospital segment influencing the growth of the infectious disease diagnostics market?
Other RELATED Reports
Healthcare-associated Infectious Disease Diagnostics Market - Global Outlook and Forecast 2019-2024
Published : October 2019
Remote Healthcare (mHealth, Tele-ICUs, & Virtual Health) Market - Global Outlook and Forecast 2020-2025
Published : July 2020
